Comparison of Two New Silicone Hydrogel Multifocal Products

Ciba Vision

Status: Completed

Conditions: Presbyopia

Treatments: Device: Lotrafilcon B multifocal contact lens; Device: Senofilcon A multifocal contact lens

Study type: Interventional

Funder types: Industry

Identifiers

NCT00823615

P-319-C-005 sub 7

Details and patient eligibility

About

The purpose of this trial is to compare the performance of two multifocal contact lenses.

Enrollment: 40 patients

Sex: All

Ages: 35+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• At least 35 years of age
• Best-corrected visual acuity of at least 20/40 in each eye.
• Spectacle add between +0.75D and +1.50D (inclusive).
• Able to be fit in available study sphere powers (-0.50 to -5.50D).
• Currently wearing soft contact lenses at least 5 days a week.
• Other protocol inclusion/exclusion criteria may apply.

Exclusion criteria

• Requires concurrent ocular medication.
• Eye injury or surgery within twelve weeks immediately prior to enrollment.
• Currently enrolled in an ophthalmic Clinical Trial.
• Evidence of systemic or ocular abnormality, infection or disease likely to affect successful wear of contact lenses or use of their accessory solutions.
• Previous refractive surgery.
• Astigmatism > 1.00D.
• Currently wearing ACUVUE OASYS for PRESBYOPIA.
• Other protocol inclusion/exclusion criteria may apply.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

40 participants in 2 patient groups

Lotrafilcon B / Senofilcon A

Other group

Description:

Lotrafilcon B, followed by Senofilcon A

Treatment:

Device: Senofilcon A multifocal contact lens

Device: Lotrafilcon B multifocal contact lens

Senofilcon A / Lotrafilcon B

Other group

Description:

Senofilcon A, followed by Lotrafilcon B

Treatment:

Device: Senofilcon A multifocal contact lens

Device: Lotrafilcon B multifocal contact lens